Cargando…

Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia

OBJECTIVES: Deficiencies in folate (FA) and vitamin B12 (VB12) are causes of macrocytic anemia. However, in clinical practice, FA and/or VB12 deficiency can occur in patients with normocytic anemia. This study aimed to determine the prevalence of FA/VB12 deficiency in patients with normocytic anemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bando, Tatsuya, Tokuda, Masutaka, Katsuda, Itsuro, Emi, Nobuhiko, Tomita, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fujita Medical Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206897/
https://www.ncbi.nlm.nih.gov/pubmed/37234385
http://dx.doi.org/10.20407/fmj.2022-016
_version_ 1785046327498899456
author Bando, Tatsuya
Tokuda, Masutaka
Katsuda, Itsuro
Emi, Nobuhiko
Tomita, Akihiro
author_facet Bando, Tatsuya
Tokuda, Masutaka
Katsuda, Itsuro
Emi, Nobuhiko
Tomita, Akihiro
author_sort Bando, Tatsuya
collection PubMed
description OBJECTIVES: Deficiencies in folate (FA) and vitamin B12 (VB12) are causes of macrocytic anemia. However, in clinical practice, FA and/or VB12 deficiency can occur in patients with normocytic anemia. This study aimed to determine the prevalence of FA/VB12 deficiency in patients with normocytic anemia and the importance of vitamin replacement therapy in these patients. METHODS: We retrospectively reviewed electronic medical record information of patients whose hemoglobin and serum FA/VB12 concentrations were measured at the Department of Hematology (N=1,388) and other departments (N=1,421) of Fujita Health University Hospital. RESULTS: In the Hematology Department, 530 (38%) patients showed normocytic anemia. Of these, 49 (9.2%) had FA/VB12 deficiency. Twenty of 49 (41%) patients had some hematological malignancies and 27 (55%) had benign hematological disorders. Of the nine patients who received vitamin replacement therapy, one showed a partial improvement in the hemoglobin concentration of ≥1 g/dL. CONCLUSIONS: In the clinical setting, the measurement of FA/VB12 concentrations in patients with normocytic anemia may be useful. Replacement therapy may be a treatment option to consider in patients with low FA/VB12 concentrations. However, physicians need to pay attention to the presence of background diseases, and the mechanisms of this situation require further investigation.
format Online
Article
Text
id pubmed-10206897
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Fujita Medical Society
record_format MEDLINE/PubMed
spelling pubmed-102068972023-05-25 Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia Bando, Tatsuya Tokuda, Masutaka Katsuda, Itsuro Emi, Nobuhiko Tomita, Akihiro Fujita Med J Original Article OBJECTIVES: Deficiencies in folate (FA) and vitamin B12 (VB12) are causes of macrocytic anemia. However, in clinical practice, FA and/or VB12 deficiency can occur in patients with normocytic anemia. This study aimed to determine the prevalence of FA/VB12 deficiency in patients with normocytic anemia and the importance of vitamin replacement therapy in these patients. METHODS: We retrospectively reviewed electronic medical record information of patients whose hemoglobin and serum FA/VB12 concentrations were measured at the Department of Hematology (N=1,388) and other departments (N=1,421) of Fujita Health University Hospital. RESULTS: In the Hematology Department, 530 (38%) patients showed normocytic anemia. Of these, 49 (9.2%) had FA/VB12 deficiency. Twenty of 49 (41%) patients had some hematological malignancies and 27 (55%) had benign hematological disorders. Of the nine patients who received vitamin replacement therapy, one showed a partial improvement in the hemoglobin concentration of ≥1 g/dL. CONCLUSIONS: In the clinical setting, the measurement of FA/VB12 concentrations in patients with normocytic anemia may be useful. Replacement therapy may be a treatment option to consider in patients with low FA/VB12 concentrations. However, physicians need to pay attention to the presence of background diseases, and the mechanisms of this situation require further investigation. Fujita Medical Society 2023-05 2022-10-28 /pmc/articles/PMC10206897/ /pubmed/37234385 http://dx.doi.org/10.20407/fmj.2022-016 Text en https://creativecommons.org/licenses/by/4.0/This is an Open access article distributed under the Terms of Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Bando, Tatsuya
Tokuda, Masutaka
Katsuda, Itsuro
Emi, Nobuhiko
Tomita, Akihiro
Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia
title Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia
title_full Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia
title_fullStr Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia
title_full_unstemmed Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia
title_short Involvement of folate and vitamin B12 deficiency in patients with normocytic anemia
title_sort involvement of folate and vitamin b12 deficiency in patients with normocytic anemia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206897/
https://www.ncbi.nlm.nih.gov/pubmed/37234385
http://dx.doi.org/10.20407/fmj.2022-016
work_keys_str_mv AT bandotatsuya involvementoffolateandvitaminb12deficiencyinpatientswithnormocyticanemia
AT tokudamasutaka involvementoffolateandvitaminb12deficiencyinpatientswithnormocyticanemia
AT katsudaitsuro involvementoffolateandvitaminb12deficiencyinpatientswithnormocyticanemia
AT eminobuhiko involvementoffolateandvitaminb12deficiencyinpatientswithnormocyticanemia
AT tomitaakihiro involvementoffolateandvitaminb12deficiencyinpatientswithnormocyticanemia